Thursday, October 25, 2012

Applications Thursday: RT-QuIC, a Faster, Higher Throughput Assay to Measure Prion Diseases

Aphis.usda.gov BSE 5Researchers at Rocky Mountain Laboratories in Hamilton, MT with collaborating scientists in Japan have developed a new assay for quantitating prions for neurodegenerative disease research. This new assay, Real-Time Quaking Induced Conversion Assay (RT-QuIC) is a faster, higher throughput, and more sensitive assay for prions than compared to previous test methods using biological tissue samples from infected animals.

BOVINE PRION PROTEIN 1dx0 asym r 500This new prion assay can be measured using BMG LABTECH’s Omega series of microplate readers . With the Omega’s powerful control and  MARS Data Analysis Software, researchers can easily perform this prion assay in several hours to a few days, compared to months with the previous technique in animals. For more information please see their publication: Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays in PLoS Pathogen (6(12): e1001217. doi:10.1371/journal.ppat.1001217).

See BMG LABTECH’s Rocky Mountain Laboratory customer focus for more information on this new prion disease assay.

1 comment:

  1. Hey! I am glad to stop by your site and know more about cancer assays. Keep it up! This is a good read. You have such an interesting and informative page. I will be looking forward to visit your page again and for your other posts as well. Thank you for sharing your thoughts about cancer assays in your area.
    Following gene identification and algorithm development, a process for conducting the assay, including all steps from receipt of the tumor specimen to generation of the assay result, was finalized and analytically validated prior to conducting clinical validation studies. Analytical validation of Oncotype DX test ensures that the assay will give accurate, precise and reproducible results across different reagent lots, operators, and patient samples. Standardization of the assay is critical to ensuring that the Oncotype DX assay yields reliable results which clinicians can use to informing patient management treatment decisions.
    Off-the-shelf Mass Spectrometry assay service available through ISO 9001:2008 accredited facility.

    Cancer Assays

    ReplyDelete

Please let us know what you think...